Evidence map›Paper›PMID 33087445›Full record

ArticleThe Journal of biological chemistry2020

PDE5 inhibition rescues mitochondrial dysfunction and angiogenic responses induced by Akt3 inhibition by promotion of PRC expression.

Daniel G Corum, Dorea P Jenkins, James A Heslop, Lacey M Tallent, Gyda C Beeson, Jeremy L Barth, Rick G Schnellmann, Robin C Muise-Helmericks

Abstract read
In one paragraph

Article in The Journal of biological chemistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. PDE5 inhibition restores mitochondrial function and improves neurobehavioral outcomes after repeated mild blast TBI.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2026
    Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. The role of gasotransmitters in Parkinson's disease: Interplay of nitric oxide, carbon monoxide, and hydrogen sulfide.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Review
  10. Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Daniel G CorumDepartment of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, South Carolina.
Dorea P JenkinsDepartment of Pathology, Medical University of South Carolina, Charleston, South Carolina.
James A HeslopDepartment of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, South Carolina.
Lacey M TallentDepartment of Bioengineering, Duke University, Durham, North Carolina.
Gyda C BeesonDepartment of Drug Discovery, Medical University of South Carolina, Charleston, South Carolina.
Jeremy L BarthDepartment of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, South Carolina.
Rick G SchnellmannDepartment of Pharmacy, University of Arizona, Tucson, Arizona.
Robin C Muise-HelmericksDepartment of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, South Carolina. Electronic address: musehelm@musc.edu.

Funding

South Carolina IDeA Networks of Biomedical Research (SC INBRE V)P20GM103499 · NIGMS · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI EDIE C GOLDSMITH · 2012 to 2026
$61.0M
TRAINING TO IMPROVE CARDIOVASCULAR THERAPIEST32HL007260 · NHLBI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI MENICK, DONALD R. · 1985 to 2021
$11.1M
A novel VEGF signaling pathway leading to mitochondrial biogenesisR01HL084565 · NHLBI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI MUISE-HELMERICKS, ROBIN C · 2007 to 2011
$1.5M
NHLBI NIH HHS R01 HL084565NHLBI NIH HHS T32 HL007260NIGMS NIH HHS P20 GM103499
6 · The paper itself

Abstract

Akt3 regulates mitochondrial content in endothelial cells through the inhibition of PGC-1α nuclear localization and is also required for angiogenesis. However, whether there is a direct link between mitochondrial function and angiogenesis is unknown. Here we show that Akt3 depletion in primary endothelial cells results in decreased uncoupled oxygen consumption, increased fission, decreased membrane potential, and increased expression of the mitochondria-specific protein chaperones, HSP60 and HSP10, suggesting that Akt3 is required for mitochondrial homeostasis. Direct inhibition of mitochondrial homeostasis by the model oxidant paraquat results in decreased angiogenesis, showing a direct link between angiogenesis and mitochondrial function. Next, in exploring functional links to PGC-1α, the master regulator of mitochondrial biogenesis, we searched for compounds that induce this process. We found that, sildenafil, a phosphodiesterase 5 inhibitor, induced mitochondrial biogenesis as measured by increased uncoupled oxygen consumption, mitochondrial DNA content, and voltage-dependent anion channel protein expression. Sildenafil rescued the effects on mitochondria by Akt3 depletion or pharmacological inhibition and promoted angiogenesis, further supporting that mitochondrial homeostasis is required for angiogenesis. Sildenafil also induces the expression of PGC-1 family member PRC and can compensate for PGC-1α activity during mitochondrial stress by an Akt3-independent mechanism. The induction of PRC by sildenafil depends upon cAMP and the transcription factor CREB. Thus, PRC can functionally substitute during Akt3 depletion for absent PGC-1α activity to restore mitochondrial homeostasis and promote angiogenesis. These findings show that mitochondrial homeostasis as controlled by the PGC family of transcriptional activators is required for angiogenic responses.

Indexed as

Cell NucleusCyclic Nucleotide Phosphodiesterases, Type 5Endothelium, VascularGene Expression RegulationHumansMitochondriaNeovascularization, PhysiologicOrganelle BiogenesisOxygen ConsumptionPhosphodiesterase 5 InhibitorsProto-Oncogene Proteins c-aktTranscription FactorsAKT3 protein, humanCyclic Nucleotide Phosphodiesterases, Type 5PDE5A protein, humanperoxisome-proliferator-activated receptor-gamma coactivator-1Phosphodiesterase 5 InhibitorsProto-Oncogene Proteins c-aktTranscription FactorsAkt3Akt3/PKBγAkt PKBangiogenesisendothelial cellsmitochondriaperoxisome proliferator–activated receptor γ coactivator-1 αPGC-1αphosphodiesterasesPPARGC1APRC

Identifiers

PMID33087445
PMCPMC7939459

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.